FIP Development Goal 3 Education & Workforce Element 

Globally, we will have: 

Transparent, contemporary and innovative processes for the quality assurance of needs-based education and training systems.

Mechanisms 

• Ensure the quality of the workforce by quality assuring the continuous development and the delivery of adequate and appropriate education and training; quality assurance needs to address academic and institutional infrastructure in order to deliver the required needs and competency-based education and training.
• Establish standards-based global guidance for quality assurance of pharmacy and pharmaceutical science education in the context of local needs and practice.
• Implement fair, effective and transparent policies and procedures for quality assurance of pharmacy and pharmaceutical science education and training.
• Define critical stakeholder input on development of adequate education and training and fair and effective policies, including necessary student input.

FIP Development Goal 3 Practice Element 

Globally, we will have: 

Transparent, contemporary and innovative processes for the quality assessment, monitoring and improvement of services in practice.

Mechanisms 

• Define standards for practice by pharmacists and pharmacy support workforce in community, hospital and other direct patient care roles.
• Develop standards-based guidance, practice support tools and self-assessment tools for the implementation and delivery of professional services that are aligned with patient, community and health system
  needs.
• Ensure systems are in place for upholding ethical practice across all areas of pharmaceutical practice.
• Establish mechanisms and indicators for quality improvement including collaborative working, patient safety and professional standards.
• Ensure the quality and effectiveness of pharmaceutical services by assuring the education, training, performance and professional development standards that develop a workforce fit to deliver those services.
• Establish mechanisms for (‘real world’) pragmatic and useful evidence-based service implementation and service evaluation and monitoring such as audit systems, patient feedback, health outcomes research and
  cost effectiveness measures.

FIP Development Goal 3 Science Element 

Globally, we will have: 

Quality and integrity in pharmaceutical research, development, manufacturing, and regulations to assure access to safe and effective medical products globally.

Mechanisms 

• Create an accessible library of guidance documents defining quality assurance criteria for various pharmaceutical sciences focus areas.
• Develop tools to improve knowledge of national regulatory requirements for medical products
• Collaborate with global and regional stakeholders to develop mechanisms aimed at reducing substandard and falsified medical products.